NTES expected to report mixed Q3 results with revenue miss due to product aging, but maintains BUY rating with promising pipeline. TP cut from US$122 to US$110.
What is covered in the Full Insight:
Introduction
C3Q24 Revenue and Profit Expectations
Impact of Aging Products
Margin Improvements
Future Pipeline Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.